Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00258791|
Recruitment Status : Withdrawn (first postponed then cancelled as national drug authority changed requirements)
First Posted : November 28, 2005
Last Update Posted : September 25, 2012
|Condition or disease||Intervention/treatment|
|Mental Disorders||Drug: Ibuprofen|
The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.
Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up .
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Double (Participant, Outcomes Assessor)|
|Official Title:||Effects of Pretreatment With Ibuprofen in Post- ECT Headache|
|Study Start Date :||January 2012|
|Primary Completion Date :||May 2012|
|Study Completion Date :||May 2012|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00258791
|Principal Investigator:||Olav Morten Linaker, MD PhD||Norwegian University of Science and Technology|